TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Vasomotor Symptoms of Menopause Treatment Market Research Report 2022

Global Vasomotor Symptoms of Menopause Treatment Market Research Report 2022

  • Category:Life Sciences
  • Published on : 25 November 2022
  • Pages :86
  • Formats:
  • Report Code:SMR-7495337
OfferClick for best price

Best Price: $2320

Market Analysis and Insights: Global Vasomotor Symptoms of Menopause Treatment Market

The global Vasomotor Symptoms of Menopause Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Vasomotor Symptoms of Menopause Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Vasomotor Symptoms of Menopause Treatment market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Vasomotor Symptoms of Menopause Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Vasomotor Symptoms of Menopause Treatment market.

Global Vasomotor Symptoms of Menopause Treatment Scope and Market Size

Vasomotor Symptoms of Menopause Treatment market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Vasomotor Symptoms of Menopause Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Estetrol
Fezolinetant
FP-101
HBN-2
Others
Segment by Application
Hospital
Homecare
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Amgen Inc.
EndoCeutics, Inc.
Euroscreen S.A.
MenoGeniX, Inc.
Mithra Pharmaceuticals S.A.
Pherin Pharmaceuticals, Inc.
Pivot Pharmaceuticals Inc
Radius Health, Inc.
TherapeuticsMD, Inc.

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Vasomotor Symptoms of Menopause Treatment product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Vasomotor Symptoms of Menopause Treatment, with price, sales, revenue, and global market share of Vasomotor Symptoms of Menopause Treatment from 2019 to 2022.

Chapter 3, the Vasomotor Symptoms of Menopause Treatment competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Vasomotor Symptoms of Menopause Treatment breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Vasomotor Symptoms of Menopause Treatment market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Vasomotor Symptoms of Menopause Treatment.

Chapter 13, 14, and 15, to describe Vasomotor Symptoms of Menopause Treatment sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Vasomotor Symptoms of Menopause Treatment Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

TABLE OF CONTENTS

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Vasomotor Symptoms of Menopause Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Estetrol
1.2.3 Fezolinetant
1.2.4 FP-101
1.2.5 HBN-2
1.2.6 Others
1.3 Market by Application
1.3.1 Global Vasomotor Symptoms of Menopause Treatment Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Homecare
1.3.4 Clinic
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Vasomotor Symptoms of Menopause Treatment Market Perspective (2017-2028)
2.2 Vasomotor Symptoms of Menopause Treatment Growth Trends by Region
2.2.1 Vasomotor Symptoms of Menopause Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Vasomotor Symptoms of Menopause Treatment Historic Market Size by Region (2017-2022)
2.2.3 Vasomotor Symptoms of Menopause Treatment Forecasted Market Size by Region (2023-2028)
2.3 Vasomotor Symptoms of Menopause Treatment Market Dynamics
2.3.1 Vasomotor Symptoms of Menopause Treatment Industry Trends
2.3.2 Vasomotor Symptoms of Menopause Treatment Market Drivers
2.3.3 Vasomotor Symptoms of Menopause Treatment Market Challenges
2.3.4 Vasomotor Symptoms of Menopause Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Vasomotor Symptoms of Menopause Treatment Players by Revenue
3.1.1 Global Top Vasomotor Symptoms of Menopause Treatment Players by Revenue (2017-2022)
3.1.2 Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Vasomotor Symptoms of Menopause Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Vasomotor Symptoms of Menopause Treatment Revenue
3.4 Global Vasomotor Symptoms of Menopause Treatment Market Concentration Ratio
3.4.1 Global Vasomotor Symptoms of Menopause Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Vasomotor Symptoms of Menopause Treatment Revenue in 2021
3.5 Vasomotor Symptoms of Menopause Treatment Key Players Head office and Area Served
3.6 Key Players Vasomotor Symptoms of Menopause Treatment Product Solution and Service
3.7 Date of Enter into Vasomotor Symptoms of Menopause Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Vasomotor Symptoms of Menopause Treatment Breakdown Data by Type
4.1 Global Vasomotor Symptoms of Menopause Treatment Historic Market Size by Type (2017-2022)
4.2 Global Vasomotor Symptoms of Menopause Treatment Forecasted Market Size by Type (2023-2028)
5 Vasomotor Symptoms of Menopause Treatment Breakdown Data by Application
5.1 Global Vasomotor Symptoms of Menopause Treatment Historic Market Size by Application (2017-2022)
5.2 Global Vasomotor Symptoms of Menopause Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Vasomotor Symptoms of Menopause Treatment Market Size (2017-2028)
6.2 North America Vasomotor Symptoms of Menopause Treatment Market Size by Country (2017-2022)
6.3 North America Vasomotor Symptoms of Menopause Treatment Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Vasomotor Symptoms of Menopause Treatment Market Size (2017-2028)
7.2 Europe Vasomotor Symptoms of Menopause Treatment Market Size by Country (2017-2022)
7.3 Europe Vasomotor Symptoms of Menopause Treatment Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size (2017-2028)
8.2 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size by Country (2017-2022)
8.3 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Vasomotor Symptoms of Menopause Treatment Market Size (2017-2028)
9.2 Latin America Vasomotor Symptoms of Menopause Treatment Market Size by Country (2017-2022)
9.3 Latin America Vasomotor Symptoms of Menopause Treatment Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Size (2017-2028)
10.2 Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Size by Country (2017-2022)
10.3 Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Amgen Inc.
11.1.1 Amgen Inc. Company Detail
11.1.2 Amgen Inc. Business Overview
11.1.3 Amgen Inc. Vasomotor Symptoms of Menopause Treatment Introduction
11.1.4 Amgen Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2017-2022)
11.1.5 Amgen Inc. Recent Development
11.2 EndoCeutics, Inc.
11.2.1 EndoCeutics, Inc. Company Detail
11.2.2 EndoCeutics, Inc. Business Overview
11.2.3 EndoCeutics, Inc. Vasomotor Symptoms of Menopause Treatment Introduction
11.2.4 EndoCeutics, Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2017-2022)
11.2.5 EndoCeutics, Inc. Recent Development
11.3 Euroscreen S.A.
11.3.1 Euroscreen S.A. Company Detail
11.3.2 Euroscreen S.A. Business Overview
11.3.3 Euroscreen S.A. Vasomotor Symptoms of Menopause Treatment Introduction
11.3.4 Euroscreen S.A. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2017-2022)
11.3.5 Euroscreen S.A. Recent Development
11.4 MenoGeniX, Inc.
11.4.1 MenoGeniX, Inc. Company Detail
11.4.2 MenoGeniX, Inc. Business Overview
11.4.3 MenoGeniX, Inc. Vasomotor Symptoms of Menopause Treatment Introduction
11.4.4 MenoGeniX, Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2017-2022)
11.4.5 MenoGeniX, Inc. Recent Development
11.5 Mithra Pharmaceuticals S.A.
11.5.1 Mithra Pharmaceuticals S.A. Company Detail
11.5.2 Mithra Pharmaceuticals S.A. Business Overview
11.5.3 Mithra Pharmaceuticals S.A. Vasomotor Symptoms of Menopause Treatment Introduction
11.5.4 Mithra Pharmaceuticals S.A. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2017-2022)
11.5.5 Mithra Pharmaceuticals S.A. Recent Development
11.6 Pherin Pharmaceuticals, Inc.
11.6.1 Pherin Pharmaceuticals, Inc. Company Detail
11.6.2 Pherin Pharmaceuticals, Inc. Business Overview
11.6.3 Pherin Pharmaceuticals, Inc. Vasomotor Symptoms of Menopause Treatment Introduction
11.6.4 Pherin Pharmaceuticals, Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2017-2022)
11.6.5 Pherin Pharmaceuticals, Inc. Recent Development
11.7 Pivot Pharmaceuticals Inc
11.7.1 Pivot Pharmaceuticals Inc Company Detail
11.7.2 Pivot Pharmaceuticals Inc Business Overview
11.7.3 Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Introduction
11.7.4 Pivot Pharmaceuticals Inc Revenue in Vasomotor Symptoms of Menopause Treatment Business (2017-2022)
11.7.5 Pivot Pharmaceuticals Inc Recent Development
11.8 Radius Health, Inc.
11.8.1 Radius Health, Inc. Company Detail
11.8.2 Radius Health, Inc. Business Overview
11.8.3 Radius Health, Inc. Vasomotor Symptoms of Menopause Treatment Introduction
11.8.4 Radius Health, Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2017-2022)
11.8.5 Radius Health, Inc. Recent Development
11.9 TherapeuticsMD, Inc.
11.9.1 TherapeuticsMD, Inc. Company Detail
11.9.2 TherapeuticsMD, Inc. Business Overview
11.9.3 TherapeuticsMD, Inc. Vasomotor Symptoms of Menopause Treatment Introduction
11.9.4 TherapeuticsMD, Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2017-2022)
11.9.5 TherapeuticsMD, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Vasomotor Symptoms of Menopause Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Estetrol
Table 3. Key Players of Fezolinetant
Table 4. Key Players of FP-101
Table 5. Key Players of HBN-2
Table 6. Key Players of Others
Table 7. Global Vasomotor Symptoms of Menopause Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Vasomotor Symptoms of Menopause Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Vasomotor Symptoms of Menopause Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Vasomotor Symptoms of Menopause Treatment Market Share by Region (2017-2022)
Table 11. Global Vasomotor Symptoms of Menopause Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Vasomotor Symptoms of Menopause Treatment Market Share by Region (2023-2028)
Table 13. Vasomotor Symptoms of Menopause Treatment Market Trends
Table 14. Vasomotor Symptoms of Menopause Treatment Market Drivers
Table 15. Vasomotor Symptoms of Menopause Treatment Market Challenges
Table 16. Vasomotor Symptoms of Menopause Treatment Market Restraints
Table 17. Global Vasomotor Symptoms of Menopause Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Vasomotor Symptoms of Menopause Treatment Market Share by Players (2017-2022)
Table 19. Global Top Vasomotor Symptoms of Menopause Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vasomotor Symptoms of Menopause Treatment as of 2021)
Table 20. Ranking of Global Top Vasomotor Symptoms of Menopause Treatment Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Vasomotor Symptoms of Menopause Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Vasomotor Symptoms of Menopause Treatment Product Solution and Service
Table 24. Date of Enter into Vasomotor Symptoms of Menopause Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Vasomotor Symptoms of Menopause Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Type (2017-2022)
Table 28. Global Vasomotor Symptoms of Menopause Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Type (2023-2028)
Table 30. Global Vasomotor Symptoms of Menopause Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Application (2017-2022)
Table 32. Global Vasomotor Symptoms of Menopause Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Application (2023-2028)
Table 34. North America Vasomotor Symptoms of Menopause Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 35. North America Vasomotor Symptoms of Menopause Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 36. Europe Vasomotor Symptoms of Menopause Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 37. Europe Vasomotor Symptoms of Menopause Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 38. Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 39. Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 40. Latin America Vasomotor Symptoms of Menopause Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 41. Latin America Vasomotor Symptoms of Menopause Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 42. Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 43. Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 44. Amgen Inc. Company Detail
Table 45. Amgen Inc. Business Overview
Table 46. Amgen Inc. Vasomotor Symptoms of Menopause Treatment Product
Table 47. Amgen Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2017-2022) & (US$ Million)
Table 48. Amgen Inc. Recent Development
Table 49. EndoCeutics, Inc. Company Detail
Table 50. EndoCeutics, Inc. Business Overview
Table 51. EndoCeutics, Inc. Vasomotor Symptoms of Menopause Treatment Product
Table 52. EndoCeutics, Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2017-2022) & (US$ Million)
Table 53. EndoCeutics, Inc. Recent Development
Table 54. Euroscreen S.A. Company Detail
Table 55. Euroscreen S.A. Business Overview
Table 56. Euroscreen S.A. Vasomotor Symptoms of Menopause Treatment Product
Table 57. Euroscreen S.A. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2017-2022) & (US$ Million)
Table 58. Euroscreen S.A. Recent Development
Table 59. MenoGeniX, Inc. Company Detail
Table 60. MenoGeniX, Inc. Business Overview
Table 61. MenoGeniX, Inc. Vasomotor Symptoms of Menopause Treatment Product
Table 62. MenoGeniX, Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2017-2022) & (US$ Million)
Table 63. MenoGeniX, Inc. Recent Development
Table 64. Mithra Pharmaceuticals S.A. Company Detail
Table 65. Mithra Pharmaceuticals S.A. Business Overview
Table 66. Mithra Pharmaceuticals S.A. Vasomotor Symptoms of Menopause Treatment Product
Table 67. Mithra Pharmaceuticals S.A. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2017-2022) & (US$ Million)
Table 68. Mithra Pharmaceuticals S.A. Recent Development
Table 69. Pherin Pharmaceuticals, Inc. Company Detail
Table 70. Pherin Pharmaceuticals, Inc. Business Overview
Table 71. Pherin Pharmaceuticals, Inc. Vasomotor Symptoms of Menopause Treatment Product
Table 72. Pherin Pharmaceuticals, Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2017-2022) & (US$ Million)
Table 73. Pherin Pharmaceuticals, Inc. Recent Development
Table 74. Pivot Pharmaceuticals Inc Company Detail
Table 75. Pivot Pharmaceuticals Inc Business Overview
Table 76. Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Product
Table 77. Pivot Pharmaceuticals Inc Revenue in Vasomotor Symptoms of Menopause Treatment Business (2017-2022) & (US$ Million)
Table 78. Pivot Pharmaceuticals Inc Recent Development
Table 79. Radius Health, Inc. Company Detail
Table 80. Radius Health, Inc. Business Overview
Table 81. Radius Health, Inc. Vasomotor Symptoms of Menopause Treatment Product
Table 82. Radius Health, Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2017-2022) & (US$ Million)
Table 83. Radius Health, Inc. Recent Development
Table 84. TherapeuticsMD, Inc. Company Detail
Table 85. TherapeuticsMD, Inc. Business Overview
Table 86. TherapeuticsMD, Inc. Vasomotor Symptoms of Menopause Treatment Product
Table 87. TherapeuticsMD, Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2017-2022) & (US$ Million)
Table 88. TherapeuticsMD, Inc. Recent Development
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Vasomotor Symptoms of Menopause Treatment Market Share by Type: 2021 VS 2028
Figure 2. Estetrol Features
Figure 3. Fezolinetant Features
Figure 4. FP-101 Features
Figure 5. HBN-2 Features
Figure 6. Others Features
Figure 7. Global Vasomotor Symptoms of Menopause Treatment Market Share by Application in 2021 & 2028
Figure 8. Hospital Case Studies
Figure 9. Homecare Case Studies
Figure 10. Clinic Case Studies
Figure 11. Vasomotor Symptoms of Menopause Treatment Report Years Considered
Figure 12. Global Vasomotor Symptoms of Menopause Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Vasomotor Symptoms of Menopause Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Vasomotor Symptoms of Menopause Treatment Market Share by Region: 2021 VS 2028
Figure 15. Global Vasomotor Symptoms of Menopause Treatment Market Share by Players in 2021
Figure 16. Global Top Vasomotor Symptoms of Menopause Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vasomotor Symptoms of Menopause Treatment as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Vasomotor Symptoms of Menopause Treatment Revenue in 2021
Figure 18. North America Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. North America Vasomotor Symptoms of Menopause Treatment Market Share by Country (2017-2028)
Figure 20. United States Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Vasomotor Symptoms of Menopause Treatment Market Share by Country (2017-2028)
Figure 24. Germany Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. France Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. U.K. Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Italy Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Russia Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Nordic Countries Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Share by Region (2017-2028)
Figure 32. China Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Japan Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. South Korea Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Southeast Asia Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. India Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Australia Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Latin America Vasomotor Symptoms of Menopause Treatment Market Share by Country (2017-2028)
Figure 40. Mexico Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Brazil Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Share by Country (2017-2028)
Figure 44. Turkey Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Saudi Arabia Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Amgen Inc. Revenue Growth Rate in Vasomotor Symptoms of Menopause Treatment Business (2017-2022)
Figure 47. EndoCeutics, Inc. Revenue Growth Rate in Vasomotor Symptoms of Menopause Treatment Business (2017-2022)
Figure 48. Euroscreen S.A. Revenue Growth Rate in Vasomotor Symptoms of Menopause Treatment Business (2017-2022)
Figure 49. MenoGeniX, Inc. Revenue Growth Rate in Vasomotor Symptoms of Menopause Treatment Business (2017-2022)
Figure 50. Mithra Pharmaceuticals S.A. Revenue Growth Rate in Vasomotor Symptoms of Menopause Treatment Business (2017-2022)
Figure 51. Pherin Pharmaceuticals, Inc. Revenue Growth Rate in Vasomotor Symptoms of Menopause Treatment Business (2017-2022)
Figure 52. Pivot Pharmaceuticals Inc Revenue Growth Rate in Vasomotor Symptoms of Menopause Treatment Business (2017-2022)
Figure 53. Radius Health, Inc. Revenue Growth Rate in Vasomotor Symptoms of Menopause Treatment Business (2017-2022)
Figure 54. TherapeuticsMD, Inc. Revenue Growth Rate in Vasomotor Symptoms of Menopause Treatment Business (2017-2022)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD GBP EURO YEN Single User Price
USD GBP EURO YEN Multi User Price
USD GBP EURO YEN Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount